<iframe src="//www.googletagmanager.com/ns.html?id=GTM-WSMCRCP" height="0" width="0" style="display:none;visibility:hidden">

Audio Commentary: COVID-19 update –a conversation with RBC Capital Markets biotech analyst Kennen MacKay

Apr 14, 2020 | RBC Wealth Management


Share

Dr. MacKay shares thoughts about the virus and whether signs of a peak in cases are evident, what's needed to reopen the U.S. economy and lessons we can learn.

Audio Commentary: COVID-19 update –a conversation with RBC Capital Markets biotech analyst Kennen MacKay

Janet Engels, Head of the Portfolio Advisory Group – U.S., interviews Dr. Kennen MacKay, Managing Director and Co-Head of Biotechnology Research for RBC Capital Markets. Kennen routinely publishes an update on the COVID-19 pandemic and the spread of the virus globally.

The conversation will include Kennen’s thoughts on where we are in the spread of the virus and whether signs of a peak in cases are evident. They’ll also talk about what’s needed to reopen the U.S. economy, the lessons we can learn from other geographic regions, and the progress being made on treatments or a vaccine.

Listen here. (Approximately 16-minute duration)

Categories

Analysis